Electroconvulsive therapy in children and adolescents: results from a population‑based study utilising the Swedish National Quality Register
Tóm tắt
Từ khóa
Tài liệu tham khảo
WHO (2022) Adolescent and young adult health. https://www.who.int/news-room/fact-sheets/detail/adolescents-health-risks-and-solutions. Accessed 10 Aug 2022
Substance Abuse and Mental Health Services Administration (2019) National survey on drug use and health. https://www.nimh.nih.gov/health/statistics/major-depression#part_2565. Accessed 10 Aug 2022
Lewinsohn PM, Hops H, Roberts RE et al (1993) Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol 102:133–144. https://doi.org/10.1037//0021-843x.102.1.133
Swedish National Board of Health and Welfare (2019) Statistics on pharmaceuticals 2018. https://www.socialstyrelsen.se/en/publications. Accessed 10 Aug 2022
Feeney A, Hock RS, Fava M et al (2022) Antidepressants in children and adolescents with major depressive disorder and the influence of placebo response: a meta-analysis. J Affect Disord 305:55–64. https://doi.org/10.1016/j.jad.2022.02.074
Hetrick S, Merry S, McKenzie J et al (2007) Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004851.pub2
Emslie GJ, Ventura D, Korotzer A et al (2009) Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry 48:721–729. https://doi.org/10.1097/CHI.0b013e3181a2b304
Findling RL, Robb A, Bose A (2013) Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial. J Child Adolesc Psychopharmacol 23:468–480. https://doi.org/10.1089/cap.2012.0023
Hetrick SE, McKenzie JE, Bailey AP et al (2021) New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Rev 5:CD013674. https://doi.org/10.1002/14651858.CD013674.pub2
Miller L, Campo JV (2021) Depression in adolescents. N Engl J Med 385:445–449. https://doi.org/10.1056/NEJMra2033475
Zhou X, Michael KD, Liu Y et al (2014) Systematic review of management for treatment-resistant depression in adolescents. BMC Psychiatry 14:340. https://doi.org/10.1186/s12888-014-0340-6
Carvalho AF, Sharma MS, Brunoni AR et al (2016) The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom 85:270–288. https://doi.org/10.1159/000447034
Castaneda-Ramirez S, Becker TD, Bruges-Boude A et al (2022) Systematic review: electroconvulsive therapy for treatment-resistant mood disorders in children and adolescents. Eur Child Adolesc Psychiatry. https://doi.org/10.1007/s00787-022-01942-7
Bender L (1947) One hundred cases of childhood schizophrenia treated with electric shock. Trans Am Neurol Soc 72:165–169
Heuyer G, Bour LR (1943) L’électrochoc chez les enfants. Ann Med Psychol (Paris) 2:402–407
Ghaziuddin N, Kutcher SP, Knapp P et al (2004) Practice parameter for use of electroconvulsive therapy with adolescents. J Am Acad Child Adolesc Psychiatry 43:1521–1539. https://doi.org/10.1097/01.chi.0000142280.87429.68
Thompson JW, Blaine JD (1987) Use of ECT in the United States in 1975 and 1980. Am J Psychiatry 144:557–562. https://doi.org/10.1176/ajp.144.5.557
Pippard J, Ellam L (1981) Electroconvulsive treatment in Great Britain. Br J Psychiatry 139:563–568. https://doi.org/10.1192/bjp.139.6.563
Elvin T, Nordenskjöld A (2016) Swedish National Quality register for ECT—annual report, vol 2017. https://ect.registercentrum.se/om-registret/kvalitetsregister-ect/p/HyUWjuR7W. Accessed 10 Aug 2022
Socialstyrelsen (2018) Läkemedelsregistret [Prescribed drug register] https://www.socialstyrelsen.se/statistik-och-data/register/lakemedelsregistret. Accessed 10 Oct 2022
Leucht S, Fennema H, Engel R et al (2013) What does the HAMD mean? J Affect Disord 148:243–248. https://doi.org/10.1016/j.jad.2012.12.001
Berk M, Ng F, Dodd S et al (2008) The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use. J Eval Clin Pract 14:979–983. https://doi.org/10.1111/j.1365-2753.2007.00921.x
Guy W (1976) ECDEU assessment manual for psychopharmacology. United States Department of Health, Education and Welfare, Rockville
Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389. https://doi.org/10.1192/bjp.134.4.382
Hanley JA, Lippman-Hand A (1983) If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 249:1743–1745. https://doi.org/10.1001/jama.1983.03330370053031
Kronsell A, Nordenskjöld A, Bell M et al (2021) The effect of anaesthetic dose on response and remission in electroconvulsive therapy for major depressive disorder: nationwide register-based cohort study. BJPsych Open 7:e71. https://doi.org/10.1192/bjo.2021.31
Blumberger DM, Seitz DP, Herrmann N et al (2017) Low medical morbidity and mortality after acute courses of electroconvulsive therapy in a population-based sample. Acta Psychiatr Scand 136:583–593. https://doi.org/10.1111/acps.12815
Ekstrand J, Fattah C, Persson M et al (2022) Racemic ketamine as an alternative to electroconvulsive therapy for unipolar depression: a randomized, open-label, non-inferiority trial (KetECT). Int J Neuropsychopharmacol 25:339–349. https://doi.org/10.1093/ijnp/pyab088
Semkovska M, McLoughlin DM (2010) Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry 68:568–577. https://doi.org/10.1016/j.biopsych.2010.06.009
Rock PL, Roiser JP, Riedel WJ et al (2014) Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med 44:2029–2040. https://doi.org/10.1017/S0033291713002535
Espinoza RT, Kellner CH (2022) Electroconvulsive therapy. N Engl J Med 386:667–672. https://doi.org/10.1056/NEJMra2034954
Petrides G, Fink M, Husain MM et al (2001) ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 17:244–253. https://doi.org/10.1097/00124509-200112000-00003
Swedish National Board of Health and Welfare (2019) Nationella riktlinjer för vård vid depression och ångestsyndrom. https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/nationella-riktlinjer/2019-5-13-enkatbilaga.pdf. Accessed 10 Aug 2022
Kaliora SC, Braga RJ, Petrides G et al (2013) The practice of electroconvulsive therapy in Greece. J ECT 29:219–224. https://doi.org/10.1097/YCT.0b013e31827e0d49
Lõokene M, Kisuro A, Mačiulis V et al (2014) Use of electroconvulsive therapy in the Baltic states. World J Biol Psychiatry 15:419–424. https://doi.org/10.3109/15622975.2013.866692
Martin BA, Delva NJ, Graf P et al (2015) Delivery of electroconvulsive therapy in Canada: a first national survey report on usage, treatment practice, and facilities. J ECT 31:119–124. https://doi.org/10.1097/YCT.0000000000000192
Schweder LJ, Lydersen S, Wahlund B et al (2011) Electroconvulsive therapy in Norway: rates of use, clinical characteristics, diagnoses, and attitude. J ECT 27:292–295. https://doi.org/10.1097/YCT.0b013e318208e24b
Nordanskog P, Hultén M, Landén M et al (2015) Electroconvulsive therapy in Sweden 2013: data from the national quality register for ECT. J ECT 31:263–267. https://doi.org/10.1097/YCT.0000000000000243
Baldessarini RJ, Tondo L, Vazquez GH et al (2012) Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I disorder patients. World Psychiatry 11:40–46. https://doi.org/10.1016/j.wpsyc.2012.01.006
Jane Costello E, Erkanli A, Angold A (2006) Is there an epidemic of child or adolescent depression? J Child Psychol Psychiatry 47:1263–1271. https://doi.org/10.1111/j.1469-7610.2006.01682.x
Grover S, Raju V, Chakrabarti S et al (2021) Use of electroconvulsive therapy in adolescents: a retrospective study. Indian J Psychol Med 43:119–124. https://doi.org/10.1177/0253717620956730
Karayağmurlu A, Coşkun M, Elboğa G et al (2020) Efficacy and safety of electroconvulsive therapy in adolescents: a retrospective chart review study from turkey. J ECT 36:54–59. https://doi.org/10.1097/YCT.0000000000000602
Maoz H, Nitzan U, Goldwyn Y et al (2018) When can we predict the outcome of an electroconvulsive therapy course in adolescents? A retrospective study. J ECT 34:104–107. https://doi.org/10.1097/YCT.0000000000000469
UK ECT Review Group (2003) Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 361:799–808. https://doi.org/10.1016/S0140-6736(03)12705-5
Letemendia FJ, Delva NJ, Rodenburg M et al (1993) Therapeutic advantage of bifrontal electrode placement in ECT. Psychol Med 23:349–360. https://doi.org/10.1017/s0033291700028452
Sackeim HA, Prudic J, Devanand DP et al (1993) Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 328:839–846. https://doi.org/10.1056/NEJM199303253281204
Nordanskog PN, Nordenskiöld A (2014) Ect, kliniska riktlinjer. Gothia Fortbildning, Stockholm
Bergsholm P, Bjølseth TM (2022) Dosing methods in electroconvulsive therapy: should the Scandinavian time-titration method be resumed? Nord J Psychiatry 76:170–176. https://doi.org/10.1080/08039488.2021.1946590
Kellner CH, Jørgensen MB (2022) Dosing methods in electroconvulsive therapy (ECT): towards the modal ECT technique. Nord J Psychiatry 76:159–161. https://doi.org/10.1080/08039488.2021.2012256
Sackeim HA, Prudic J, Nobler MS et al (2008) Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul 1:71–83. https://doi.org/10.1016/j.brs.2008.03.001